Molecular/Genetic Therapies in Ovarian Cancer
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Obstetrics and Gynecology
Reference30 articles.
1. Overview of anti-angiogenic agents in development for ovarian cancer.;Burger;Gynecol Oncol,2011
2. Tumor angiogenesis in advanced stage ovarian carcinoma.;Hollingsworth;Am J Pathol,1995
3. Incorporation of bevacizumab in the primary treatment of ovarian cancer.;Burger;N Engl J Med,2011
4. A phase 3 trial of bevacizumab in ovarian cancer.;Perren;N Engl J Med,2011
5. Phase II trial of bevacizumab in persistent or recurrent epithelial ovarian cancer or primary peritoneal cancer: a Gynecologic Oncology Group Study.;Burger;J Clin Oncol,2007
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Golgi phosphoprotein 3 promotes ovarian cancer progression and is associated with cisplatin resistance;Journal of Cancer Research and Therapeutics;2022
2. Primary Cytoreductive Surgery Versus Interval Debulking Surgery Following Neoadjuvant Chemotherapy in Epithelial Ovarian Cancer: An Institutional Review;Indian Journal of Gynecologic Oncology;2019-01-07
3. ERp57‑small interfering RNA silencing can enhance the sensitivity of drug‑resistant human ovarian cancer cells to paclitaxel;International Journal of Oncology;2018-11-07
4. Outcomes of advanced epithelial ovarian cancer treated with neoadjuvant chemotherapy;Indian Journal of Cancer;2018
5. The role of pazopanib on tumour angiogenesis and in the management of cancers: A review;Biomedicine & Pharmacotherapy;2017-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3